The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
Verywell Health on MSN1d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback